Previously submitted to: JMIR Research Protocols (no longer under consideration since Dec 30, 2021)
Date Submitted: Aug 18, 2020
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
The challenges and opportunities of EMR interoperability in Substance Use Disorder Treatment in Qatar
ABSTRACT
Poor EMR interoperability is a challenge in all areas of healthcare. The area of SUD is one of the disciplines in healthcare, which has relatively stayed behind from the common health care when it comes to sharing clinical information about patients with SUD (Tai & McLellan, 2012; Udi Ghitza, 2014). SUD refers to prolonged and repeated use of psychoactive substances such as opioids, nicotine, depressants, alcohol, hallucinogens and cannabinoids at high doses and/or high frequencies (Mclellan, 2017). Except for the use of tobacco, most of the clinical records about SUD are not being stored or collected within the mainstream EMRs. The issue of poor EMR interoperability around patients with SUD is well acknowledged, but there are very few empirical studies on the topic. Two recently published systematic literature reviews within the area of EMR interoperability highlighted the issue, but none of the studies included in these reviews was focused on EMR interoperability around patients with SUD (Dobrow et al., 2019; Kruse et al., 2018). Literature review on facilitators and barriers in the adoption of EMRs highlight poor EMR interoperability (Kruse et al., 2018). Another systematic literature review that evaluated global evidence on the adoption, utilization and effect of EMR interoperability revealed that none of the studies was on the topic of SUD or mental health care challenges (Dobrow et al., 2019). A possible reason for this lack of evidence is the difficulty of recruiting SUD patients for such empirical studies (Quanbeck et al., 2018). Some studies have explored perceptions of healthcare professionals about the adoption of EMRs in mental healthcare settings. For example, Odom & Willeumier (2018) argue that behavioural healthcare professionals are less likely to use EMRs because they don’t perceive EMRs as useful in their daily practice. An example is a combination of excessive documentation result in physicians being overburdened and burned out. A recent study found that physicians spend approximately 33% of their work hours performing direct clinical work and 49% completing clerical tasks and interfacing with the EHR. For every hour of clinical work, physicians spent two hours on clerical or EHR-related tasks (Friedberg MW, Chen PG, Van Busum KR, 2017). Several other studies have reported the slower adoption of EMR in general behavioural health care settings (Matthews, 2017; Shank et al., 2012; Ghitza et al., 2013). However, none of the existing studies has empirically studied the poor EMR interoperability in patients with SUD. There is limited evidence on EMR interoperability around patients with SUD, both globally and in Qatar. While the lack of interoperability between EMRs within the context of patients with SUD is a recognized problem, no empirical studies have determined the extent of the challenges and possibilities that exist to improve the EMR interoperability around patients with SUD in Qatar. In conclusion, this study addresses this lack of empirical studies by exploring the magnitude of the challenges of EMR interoperability between SUD treatment providers, and the possibilities that exist that can be exploited to overcome these challenges.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.